The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

The approval was based on a comprehensive clinical data package that included a phase 3 trial comparing denosumab-qbde with Prolia in 473 women with postmenopausal osteoporosis.

You're checking your financial account online, moving money or paying bills, when suddenly a pop-up appears. It looks exactly like your bank's page, complete with logo and branding, but asks for ...

Pfizer is facing a landmark lawsuit in the US brought on behalf of more than 1,000 women who say they developed brain tumors after taking the popular contraceptive injection Depo-Provera. On Monday, ...

The Trump administration is pulling a federal watchdog off the beat in Washington, effective Wednesday, stripping funding from the Council of Inspectors General. Removing the council's funding will ...

Environmental enforcement has hit historic lows, as the Trump administration has brought fewer lawsuits against companies for environmental violations in its first six months than any other ...

In a significant shift in U.S. industrial policy, the Donald Trump administration has acquired direct ownership stakes in five major publicly traded companies. This series of interventions, framed as ...

In the past few weeks, several biosimilar products have been granted marketing authorization in Europe and Japan, and additional products have been recommended for approval in Europe. In 2022, ...

The Trump administration has pushed back its plans to roll out economic aid for farmers this week due to the government shutdown, according to four people familiar with the talks. The Office of ...

This is read by an automated voice. Please report any issues or inconsistencies here. California, 10 other states and D.C. sued, arguing the cuts illegally cost them hundreds of millions in emergency ...

This is read by an automated voice. Please report any issues or inconsistencies here. A federal judge rules the Trump administration unconstitutionally targeted noncitizens for deportation over Gaza ...

"Men don't do as well in recovery as women," she said, with higher rates of death (25% to 30% within a year), disability, and institutionalization. "A 50-year-old man is more likely to die from the ...